BioSpace News Archive

- Company to present interim results from the Phase 1 clinical trial of MVT-1075, a radioimmunotherapy product for the treatment of patients with relapsed / refractory pancreatic cancer - Company to present results from preclinical work on a fully human antibody that binds to Tn and sTn antigens that are expressed on ovarian and breast cancers

Incyte Corporation (Nasdaq:INCY) announces that 15 abstracts from its research and development portfolio will be presented at the upcoming 2018 American Association for Cancer Research (AACR) annual meeting in Chicago, Illinois from April 14-18, 2018.

Spherix Incorporated (SPEX), a technology development company committed to the fostering of innovation and monetization of intellectual property, today announced that it has priced a registered public offering on a “best efforts” basis of an aggregate of 2,222,222 shares of common stock at a price to the public of $1.35 per share.

Life Sciences Pennsylvania recognized CSL Behring’s commitment to patients for its novel subcutaneous C1 esterase inhibitor, HAEGARDA®, to prevent swelling caused by the rare genetic disorder

Bayer announced a nationwide call for the beekeeping industry’s next generation of leaders, researchers and change-makers to apply for the Bayer Bee Care Young Beekeeper Award.

Newly released artificial intelligence (AI)-driven TissueMark software[1] empowers research labs to enhance quality and reliability, and reduce costs

ReddyPort Inc. announced today that it received United States regulatory clearance from the Food and Drug Administration (FDA) for its ReddyPort NIV Access Elbow (www.ReddyPort.com).

Patients showed significant improvements in cognitive function, levels of fatigue and ability to perform daily tasks

Population Health Study Begins Clinical Care Integration and Opens Genomic Testing to 40,000 Nevadans

Program teaches students about the dangers of opioid misuse and abuse.